Key Points
- Major shareholder Charles Jobson bought 5,240 shares on Jan. 6 at $8.89 each for a total of $46,583.60, raising his holding to 1,621,671 shares (a 0.32% increase, roughly $14.42M in value).
- Joint reported quarterly EPS of $0.02 (beating the -$0.01 estimate) on $13.38M revenue but still shows a negative net margin (-1.78%); the stock trades near $8.98 with a 52‑week range of $7.50–$13.47 and a market cap of about $133.5M.
- Institutional investors own 76.88% of the company with several funds recently adding to positions, while analysts hold a mixed view—consensus rating "Hold" with a $17 target price.
The Joint Corp. (NASDAQ:JYNT - Get Free Report) major shareholder Charles Jobson purchased 5,240 shares of Joint stock in a transaction dated Tuesday, January 6th. The shares were purchased at an average cost of $8.89 per share, for a total transaction of $46,583.60. Following the transaction, the insider owned 1,621,671 shares in the company, valued at approximately $14,416,655.19. This trade represents a 0.32% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.
Joint Stock Up 1.7%
NASDAQ:JYNT opened at $8.98 on Friday. The Joint Corp. has a 52 week low of $7.50 and a 52 week high of $13.47. The stock's fifty day moving average is $8.53 and its two-hundred day moving average is $9.72. The company has a market capitalization of $133.53 million, a P/E ratio of -149.64 and a beta of 1.29.
Joint (NASDAQ:JYNT - Get Free Report) last issued its quarterly earnings data on Friday, November 7th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.03. Joint had a negative net margin of 1.78% and a negative return on equity of 0.98%. The firm had revenue of $13.38 million for the quarter, compared to analyst estimates of $13.36 million. Sell-side analysts anticipate that The Joint Corp. will post 0.11 earnings per share for the current fiscal year.
Institutional Trading of Joint
Several hedge funds and other institutional investors have recently added to or reduced their stakes in JYNT. Skylands Capital LLC boosted its holdings in Joint by 6.8% in the third quarter. Skylands Capital LLC now owns 832,278 shares of the company's stock valued at $7,940,000 after acquiring an additional 52,983 shares during the last quarter. JCP Investment Management LLC grew its position in Joint by 24.0% in the third quarter. JCP Investment Management LLC now owns 593,906 shares of the company's stock valued at $5,666,000 after acquiring an additional 115,062 shares in the last quarter. Topline Capital Management LLC increased its stake in Joint by 18.7% during the 2nd quarter. Topline Capital Management LLC now owns 449,204 shares of the company's stock worth $5,184,000 after buying an additional 70,910 shares during the period. Geode Capital Management LLC lifted its stake in shares of Joint by 17.6% in the second quarter. Geode Capital Management LLC now owns 345,330 shares of the company's stock worth $3,986,000 after acquiring an additional 51,704 shares in the last quarter. Finally, First Foundation Advisors raised its position in shares of Joint by 47.8% in the 3rd quarter. First Foundation Advisors now owns 273,759 shares of the company's stock valued at $2,612,000 after purchasing an additional 88,486 shares in the last quarter. Hedge funds and other institutional investors own 76.88% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on JYNT shares. B. Riley downgraded shares of Joint from a "buy" rating to a "hold" rating in a research note on Friday, November 7th. Weiss Ratings reiterated a "sell (e+)" rating on shares of Joint in a research note on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $17.00.
Get Our Latest Analysis on JYNT
About Joint
(
Get Free Report)
The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.
Joint's growth strategy centers on partnering with franchisees to expand its network of clinics.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
